Literature DB >> 20056084

[Role of transcription factor T-bet and Eomes in IFN-gamma secretion of different human T cell subsets].

Hong-tao Wang1, Xiao-song Ge, Zhu-ping Xue, Bai-qing Li.   

Abstract

AIM: To investigate the effect of siRNAs specific for T-bet and Eomesodermin (Eomes) in interferon-gamma (IFN-gamma) production of different human T cell subsets.
METHODS: Double-stranded small interfering RNA (siRNA) sequences specific for genes of T-bet and Eomes were chemically synthesized and transfected into anti-CD3 mAb activated alphabeta T cells and Mtb-Ag activated gammadelta T cells. CD4(+), CD8(+) T and gammadelta T cells were sorted by flow cytometry and the expressions of T-bet and Eomes gene mRNA were detected by RT-PCR technique. The changes of IFN-gamma production were determined by flow cytometry.
RESULTS: After two series of transfection, the siRNA-FAM(+) cells were about 50% in the transfected cells. The IFN-gamma(+) cells in CD4(+) T cells (50.20%) decreased in the cells transfected with T-bet siRNA (18.46%) but no obvious decrease was observed in the cells transfected with Eomes siRNA, whereas the IFN-gamma(+) cells in CD8(+) T cells (76.51%) decreased in the cells transfected with Eomes siRNA (25.37%) and no obvious decrease was observed in the cells transfected with T-bet siRNA. However, the IFN-gamma producing cells in gammadelta T cells (76.52%) decreased in the cells transfected with T-bet siRNA (56.57%) or with Eomes siRNA (42.53%).
CONCLUSION: At the level of transcription factors, T-bet and Eomes are important transcription factors for the regulation of IFN-gamma production in CD4(+) and CD8(+) T cells, respectively. Both T-bet and Eomes may simultaneously be involved in the regulation of the IFN-gamma production of gammadeltaT cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20056084

Source DB:  PubMed          Journal:  Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi        ISSN: 1007-8738


  1 in total

Review 1.  Sarcoidosis: Immunopathogenesis and Immunological Markers.

Authors:  Wei Sheng Joshua Loke; Cristan Herbert; Paul S Thomas
Journal:  Int J Chronic Dis       Date:  2013-07-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.